Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China
Signed February 5, 2025·Donald Trump·90 FR 9277
Source
Everything on this page is drawn from the Federal Register, the official daily journal of the United States government. Where this page and the source disagree, the source governs.
Plain-language summary
Amends the executive order of February 1, 2025, which imposed duties addressing the synthetic opioid supply chain in the People's Republic of China. It replaces the provision on duty-free de minimis treatment (under 19 U.S.C. 1321) for covered articles subject to the tariffs. Under the revised language, de minimis treatment remains available for eligible covered articles until the Secretary of Commerce notifies the President that adequate systems are in place to fully and promptly process and collect the applicable tariff revenue on those articles, at which point de minimis treatment for them ends. The order states it does not alter existing legal authority of federal agencies or the Office of Management and Budget, must be implemented consistent with applicable law and available appropriations, and does not create enforceable rights against the United States.
Not written or reviewed by a person. Read the full order below for anything you intend to rely on.
Report a problem with this summary
Legal standing
Not yet published. Court challenges, injunctions and rulings tied to individual orders will appear here once each can be linked to its source record.
Nothing appears in this space without a citation to a court action or a cited precedent. An order with no such record is described as untested, never as likely or unlikely to survive.
Claimed authority
By the authority vested in me as President by the Constitution and the laws of the United States of America, including the International Emergency Economic Powers Act (50 U.S.C. 1701 et seq.), the National Emergencies Act (50 U.S.C. 1601 et seq.), section 604 of the Trade Act of 1974, as amended (19 U.S.C. 2483), and section 301 of title 3, United States Code, I hereby
Quoted from the order as written. Many orders cite nothing more specific than “the Constitution and the laws”; this reproduces what the order claims, not an assessment of whether it holds.
Disposition
See: EO 14195, February 1, 2025; EO 14228, March 3, 2025; EO 14256, April 2, 2025; EO 14324, July 30, 2025
Compiled after the fact by the National Archives, so recent orders often have none yet. An empty disposition means no record, not no activity.
The order, in full
Executive Order 14200 of February 5, 2025
Amendment to Duties Addressing the Synthetic
Opioid Supply Chain in the People's Republic of China
By the authority vested in me as President by the
Constitution and the laws of the United States of
America, including the International Emergency Economic
Powers Act (50 U.S.C. 1701 et seq.), the National
Emergencies Act (50 U.S.C. 1601 et seq.), section 604
of the Trade Act of 1974, as amended (19 U.S.C. 2483),
and section 301 of title 3, United States Code, I
hereby determine and order:
Section 1. Amendment. Regarding the Executive Order of
February 1, 2025 (Imposing Duties to Address the
Synthetic Opioid Supply Chain in the People's Republic
of China), the following shall replace subsection (g)
of section 2:
“(g) Duty-free de minimis treatment under 19
U.S.C. 1321 is available for otherwise eligible covered
articles described in subsection (a) of this section,
but shall cease to be available for such articles upon
notification by the Secretary of Commerce to the
President that adequate systems are in place to fully
and expediently process and collect tariff revenue
applicable pursuant to subsection (a) of this section
for covered articles otherwise eligible for de minimis
treatment.”
Sec. 2. General Provisions. (a) Nothing in this order
shall be construed to impair or otherwise affect:
(i) the authority granted by law to an executive department, agency, or the
head thereof; or
(ii) the functions of the Director of the Office of Management and Budget
relating to budgetary, administrative, or legislative proposals.
(b) This order shall be implemented consistent with
applicable law and subject to the availability of
appropriations.
(c) This order is not intended to, and does not,
create any right or benefit, substantive or procedural,
enforceable at law or in equity by any party against
the United States, its departments, agencies, or
entities, its officers, employees, or agents, or any
other person.
(Presidential Sig.)
THE WHITE HOUSE,
February 5, 2025.Reproduced from the Federal Register plain-text record, signed February 5, 2025. Typesetting artifacts are removed; no wording is changed.